Provided by Tiger Trade Technology Pte. Ltd.

Biomarin Pharmaceutical

58.39
-0.0550-0.09%
Volume:21.45K
Turnover:1.26M
Market Cap:11.28B
PE:154.06
High:58.62
Open:58.52
Low:58.39
Close:58.44
52wk High:70.98
52wk Low:49.26
Shares:193.27M
Float Shares:192.12M
Volume Ratio:4.25
T/O Rate:0.01%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.3790
EPS(LYR):1.80
ROE:1.18%
ROA:3.26%
PB:1.78
PE(LYR):32.44

Loading ...

May 09, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Apr 28, 2023

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 26, 2023

Major Issues Report

8-K - Current report
Apr 10, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Apr 06, 2023

Correspondence

CORRESP [Cover] - Correspondence
Apr 06, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Apr 03, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Mar 13, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Mar 10, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Feb 27, 2023

Major Issues Report

8-K - Current report
Feb 27, 2023

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 13, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 09, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 09, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 11, 2023

Major Issues Report

8-K - Current report
Dec 21, 2022

Major Issues Report

8-K - Current report
Oct 28, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 26, 2022

Major Issues Report

8-K - Current report
Oct 07, 2022

Major Issues Report

8-K - Current report